文献速递神经免疫

软脑膜钆增强在慢性神经炎性疾病谱中的表现

Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases.
PubMed 文献 · Neurology · 2017-03-10

本研究在两家学术研究医院比较了多发性硬化(MS)与多种炎性及非炎性神经系统疾病中软脑膜增强(LME)的患病率与特异性。结果显示LME并非MS特异,在非MS炎性神经系统疾病中频繁出现,尤其HTLV相关脊髓病患病率最高。

要点

  • LME在非MS病例中占22%,与MS的25%相近,提示其并非MS特异。
  • 非MS炎性神经系统疾病LME患病率35%,高于非炎性疾病和健康志愿者的8%。
  • HTLV感染LME患病率45%,HTLV相关脊髓病达56%,为最高。

核心结论

  • LME并非MS特异,在非MS炎性神经系统疾病中频繁出现,尤其HTLV相关脊髓病。
  • LME可能定位炎症相关的血-脑膜屏障局灶破坏及伴随瘢痕形成。

研究设计与样本

  • 在两家学术研究医院开展,评估3T增强后T2-FLAIR图像上软脑膜局灶钆增强。
  • 纳入254例非MS神经系统疾病或嗜神经病毒感染患者,并对比299例MS病例。

主要发现

  • 非MS病例LME为56/254(22%),MS病例为74/299(25%)。
  • 非MS炎性神经系统疾病LME为18/51(35%),非炎性疾病为3/38(8%),健康志愿者为5/66(8%)。
  • HTLV感染LME为17/38(45%),HTLV相关脊髓病为14/25(56%)。
  • HIV感染LME为13/61(21%)。
  • 非MS炎性神经系统疾病(包括HTLV和HIV感染)中LME与较低脑体积和皮质体积无关。

临床怎么用

  • 解读MS患者软脑膜增强时需考虑其他炎性神经系统疾病及HTLV、HIV感染的可能。
  • HTLV相关脊髓病患者出现LME的概率较高,可作为鉴别诊断线索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the prevalence and the specificity of leptomeningeal enhancement (LME) on postcontrast T2-fluid-attenuated inversion recovery (FLAIR) MRI in multiple sclerosis (MS) compared to a variety of inflammatory and noninflammatory neurologic conditions assessed in 2 academic research hospitals. METHODS: On 3T postcontrast T2-FLAIR images, the presence of focal gadolinium enhancement was evaluated in the leptomeningeal compartment in 254 people with non-MS neurologic conditions or neurotropic viral infections. Based on their clinical diagnosis, patients were grouped as follows: (1) other-than-MS inflammatory neurologic diseases; (2) noninflammatory neurologic diseases; (3) human T-lymphotropic virus (HTLV)-infected; (4) HIV-infected; (5) healthy volunteers. RESULTS: LME was detected in 56/254 non-MS cases (22%) vs 74/299 (25%) of MS cases. LME was nearly 4-fold more frequent in non-MS inflammatory neurologic conditions (18/51 cases, 35%) than in noninflammatory neurologic conditions (3/38, 8%) and healthy volunteers (5/66, 8%). The highest prevalence of LME was detected in HTLV infection (17/38 cases, 45%), particularly in the setting of HTLV-associated myelopathy (14/25 cases, 56%). LME also frequently occurred in HIV infection (13/61 cases, 21%). Unlike in MS, LME is not associated with lower brain and cortical volumes in non-MS inflammatory neurologic conditions, including HTLV and HIV infection. CONCLUSIONS: Despite its relevance to MS pathogenesis and cortical pathology, LME is not specific to MS, occurring frequently in non-MS inflammatory neurologic conditions and especially in those patients with HTLV-associated myelopathy. Overall, this strengthens the notion that LME localizes inflammation-related focal disruption of the blood-meninges barrier and associated scarring.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Absinta M, Cortese IC, Vuolo L, et al. Leptomeningeal gadolinium enhancement across the spectrum of chronic neuroinflammatory diseases. Neurology. 2017. PMID: 28283598. doi:10.1212/WNL.0000000000003820

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。